MedPath

Lypstaplus� (EZETIMIBE 10MG/ROSUVASTATIN 20MG) FILM COATED TABLET

Registration Number: MAL25036007ACZ

Approved
Approval ID

b51e51bfbe1dbac4

Registration Number

MAL25036007ACZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types3 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (3)

10 TabletsAvailable
Package Size: 10 Tablets
Status: NPRA Approved
30 TabletsAvailable
Package Size: 30 Tablets
Status: NPRA Approved
60 TabletsAvailable
Package Size: 60 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (2)

ROSUVASTATIN CALCIUMActive
Monograph: 瑞舒伐他汀
EZETIMIBEActive
Monograph: 依折麦布

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.